Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 4004 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#4004, RRID:AB_2206275
- Product name
- Phospho-Troponin I (Cardiac) (Ser23/24) Antibody
- Antibody type
- Polyclonal
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Storage
- -20°C
Submitted references Reverse myocardial effects of intermedin in pressure-overloaded hearts: role of endothelial nitric oxide synthase activity.
Endogenous regulation of cardiovascular function by apelin-APJ.
Phosphodiesterase 4 and phosphatase 2A differentially regulate cAMP/protein kinase a signaling for cardiac myocyte contraction under stimulation of beta1 adrenergic receptor.
Single histidine-substituted cardiac troponin I confers protection from age-related systolic and diastolic dysfunction.
Tyrosine phosphorylation modifies protein kinase C delta-dependent phosphorylation of cardiac troponin I.
Serotonin increases L-type Ca2+ current and SR Ca2+ content through 5-HT4 receptors in failing rat ventricular cardiomyocytes.
Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function.
Pires AL, Pinho M, Alves BS, Pinho S, Sena C, Seica RM, Leite-Moreira AF
The Journal of physiology 2013 Feb 1;591(3):677-87
The Journal of physiology 2013 Feb 1;591(3):677-87
Endogenous regulation of cardiovascular function by apelin-APJ.
Charo DN, Ho M, Fajardo G, Kawana M, Kundu RK, Sheikh AY, Finsterbach TP, Leeper NJ, Ernst KV, Chen MM, Ho YD, Chun HJ, Bernstein D, Ashley EA, Quertermous T
American journal of physiology. Heart and circulatory physiology 2009 Nov;297(5):H1904-13
American journal of physiology. Heart and circulatory physiology 2009 Nov;297(5):H1904-13
Phosphodiesterase 4 and phosphatase 2A differentially regulate cAMP/protein kinase a signaling for cardiac myocyte contraction under stimulation of beta1 adrenergic receptor.
De Arcangelis V, Soto D, Xiang Y
Molecular pharmacology 2008 Nov;74(5):1453-62
Molecular pharmacology 2008 Nov;74(5):1453-62
Single histidine-substituted cardiac troponin I confers protection from age-related systolic and diastolic dysfunction.
Palpant NJ, Day SM, Herron TJ, Converso KL, Metzger JM
Cardiovascular research 2008 Nov 1;80(2):209-18
Cardiovascular research 2008 Nov 1;80(2):209-18
Tyrosine phosphorylation modifies protein kinase C delta-dependent phosphorylation of cardiac troponin I.
Sumandea MP, Rybin VO, Hinken AC, Wang C, Kobayashi T, Harleton E, Sievert G, Balke CW, Feinmark SJ, Solaro RJ, Steinberg SF
The Journal of biological chemistry 2008 Aug 15;283(33):22680-9
The Journal of biological chemistry 2008 Aug 15;283(33):22680-9
Serotonin increases L-type Ca2+ current and SR Ca2+ content through 5-HT4 receptors in failing rat ventricular cardiomyocytes.
Birkeland JA, Swift F, Tovsrud N, Enger U, Lunde PK, Qvigstad E, Levy FO, Sejersted OM, Sjaastad I
American journal of physiology. Heart and circulatory physiology 2007 Oct;293(4):H2367-76
American journal of physiology. Heart and circulatory physiology 2007 Oct;293(4):H2367-76
Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function.
Haworth RS, Cuello F, Herron TJ, Franzen G, Kentish JC, Gautel M, Avkiran M
Circulation research 2004 Nov 26;95(11):1091-9
Circulation research 2004 Nov 26;95(11):1091-9
No comments: Submit comment
No validations: Submit validation data